Next Article in Journal
Immune Response to Human Metapneumovirus Infection: What We Have Learned from the Mouse Model
Next Article in Special Issue
The Role of Gammaherpesviruses in Cancer Pathogenesis
Previous Article in Journal
Systems Level Dissection of Candida Recognition by Dectins: A Matter of Fungal Morphology and Site of Infection
Previous Article in Special Issue
Experimental West Nile Virus Infection in Rabbits: An Alternative Model for Studying Induction of Disease and Virus Control
Open AccessReview

Nonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model)

1
Vaccine & Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Ave, Beaverton, OR 97006, USA
2
Division of Biomedical Sciences, School of Medicine, University of California-Riverside, Riverside, CA 92521, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Thomas E. “Tem” Morrison
Pathogens 2015, 4(3), 662-681; https://doi.org/10.3390/pathogens4030662
Received: 17 August 2015 / Revised: 4 September 2015 / Accepted: 9 September 2015 / Published: 16 September 2015
(This article belongs to the Special Issue Viral Pathogenesis)
Chikungunya virus (CHIKV) is a positive-sense RNA virus transmitted by Aedes mosquitoes. CHIKV is a reemerging Alphavirus that causes acute febrile illness and severe and debilitating polyarthralgia of the peripheral joints. Huge epidemics and the rapid spread of CHIKV seen in India and the Indian Ocean region established CHIKV as a global health concern. This concern was further solidified by the recent incursion of the virus into the Western hemisphere, a region without pre-existing immunity. Nonhuman primates (NHPs) serve as excellent animal models for understanding CHIKV pathogenesis and pre-clinical assessment of vaccines and therapeutics. NHPs present advantages over rodent models because they are a natural amplification host for CHIKV and they share significant genetic and physiological homology with humans. CHIKV infection in NHPs results in acute fever, rash, viremia and production of type I interferon. NHPs develop CHIKV-specific B and T-cells, generating neutralizing antibodies and CHIKV-specific CD4+ and CD8+ T-cells. CHIKV establishes a persistent infection in NHPs, particularly in cynomolgus macaques, because infectious virus could be recovered from spleen, liver, and muscle as late as 44 days post infection. NHPs are valuable models that are useful in preclinical testing of vaccines and therapeutics and uncovering the details of CHIKV pathogenesis. View Full-Text
Keywords: chikungunya virus; nonhuman primate; polyarthritis; pathogenesis; immunity chikungunya virus; nonhuman primate; polyarthritis; pathogenesis; immunity
MDPI and ACS Style

Broeckel, R.; Haese, N.; Messaoudi, I.; Streblow, D.N. Nonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model). Pathogens 2015, 4, 662-681.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop